Terms: = Bone cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4
37 results:
1. Development of a novel six DNA damage response-related prognostic signature in osteosarcoma.
Li T; Tang Z; Li S; Lu M
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):110-115. PubMed ID: 38650147
[TBL] [Abstract] [Full Text] [Related]
2. Novel Pathways between Invasiveness Modulators in Breast cancer Single Cells.
Eliceiri GL
Crit Rev Eukaryot Gene Expr; 2024; 34(2):73-75. PubMed ID: 38073443
[TBL] [Abstract] [Full Text] [Related]
3. Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126.
McDonald AM; DeMora L; Yang ES; Hoyle JM; Lenzie A; Williams GR; Michalski JM; Yee D; Bahary JP; Den RB; Roach M; Dess R; Mishra MV; Valicenti RK; Lau HY; Marcrom SR; Souhami L; Mendez LC; Chen Y; Doncals DE; Pugh SL; Feng FY; Sandler HM
Cancer; 2023 Mar; 129(5):685-696. PubMed ID: 36579470
[TBL] [Abstract] [Full Text] [Related]
4. The Yin and Yang of erbb4: Tumor Suppressor and Oncoprotein.
Lucas LM; Dwivedi V; Senfeld JI; Cullum RL; Mill CP; Piazza JT; Bryant IN; Cook LJ; Miller ST; Lott JH; Kelley CM; Knerr EL; Markham JA; Kaufmann DP; Jacobi MA; Shen J; Riese DJ
Pharmacol Rev; 2022 Jan; 74(1):18-47. PubMed ID: 34987087
[TBL] [Abstract] [Full Text] [Related]
5. Human epidermal growth factor receptor 2-positive metastatic breast cancer with novel epidermal growth factor receptor -ZNF880 fusion and epidermal growth factor receptor E114K mutations effectively treated with pyrotinib: A case report.
Yue L; Wentao L; Xin Z; Jingjing H; Xiaoyan Z; Na F; Tonghui M; Dalin L
Medicine (Baltimore); 2020 Dec; 99(51):e23406. PubMed ID: 33371069
[TBL] [Abstract] [Full Text] [Related]
6. Percutaneous image-guided thermal ablation of bone metastases: a retrospective propensity study comparing the safety profile of radio-frequency ablation and cryo-ablation.
De Marini P; Cazzato RL; Auloge P; Koch G; Dalili D; Garnon J; Gangi A
Int J Hyperthermia; 2020; 37(1):1386-1394. PubMed ID: 33322960
[TBL] [Abstract] [Full Text] [Related]
7. her4 promotes cancer metabolic reprogramming via the c-Myc-dependent signaling axis.
Han J; Zhang Y; Xu J; Zhang T; Wang H; Wang Z; Jiang Y; Zhou L; Yang M; Hua Y; Cai Z
Cancer Lett; 2021 Jan; 496():57-71. PubMed ID: 33038488
[TBL] [Abstract] [Full Text] [Related]
8. her4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway.
Li X; Huang Q; Wang S; Huang Z; Yu F; Lin J
Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):345-362. PubMed ID: 32181480
[TBL] [Abstract] [Full Text] [Related]
9. Advanced development of ErbB family-targeted therapies in osteosarcoma treatment.
Wang W; Zhao HF; Yao TF; Gong H
Invest New Drugs; 2019 Feb; 37(1):175-183. PubMed ID: 30353245
[TBL] [Abstract] [Full Text] [Related]
10. Challenges in next generation sequencing analysis of somatic mutations in transplant patients.
Chen H; Luthra R; Patel KP; Routbort M; Rashid A; Roy-Chowdhuri S; Lazar A; Broaddus R; Manekia J; Singh RR; Yemelyanova A
Cancer Genet; 2018 Oct; 226-227():17-22. PubMed ID: 30005850
[TBL] [Abstract] [Full Text] [Related]
11. How does iliosacral bone tumor resection without reconstruction affect the ipsilateral hip joint?
Jin T; Liu W; Xu H; Li Y; Hao L; Niu X
BMC Musculoskelet Disord; 2018 Apr; 19(1):102. PubMed ID: 29615012
[TBL] [Abstract] [Full Text] [Related]
12. her4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1.
Wang H; Sun W; Sun M; Fu Z; Zhou C; Wang C; Zuo D; Zhou Z; Wang G; Zhang T; Xu J; Chen J; Wang Z; Yin F; Duan Z; Hornicek FJ; Cai Z; Hua Y
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1839-1849. PubMed ID: 29524631
[TBL] [Abstract] [Full Text] [Related]
13. Expressions and clinical significance of her4 and CD44 in sinonasal mucosal malignant melanoma.
Zhu W; Li S; Zou B; Liu H; Wang S
Melanoma Res; 2018 Apr; 28(2):105-110. PubMed ID: 29309357
[TBL] [Abstract] [Full Text] [Related]
14. Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors.
Dembla V; Groisberg R; Hess K; Fu S; Wheler J; Hong DS; Janku F; Zinner R; Piha-Paul SA; Ravi V; Benjamin RS; Patel S; Somaiah N; Herzog CE; Karp DD; Roszik J; Meric-Bernstam F; Subbiah V
Sci Rep; 2017 Nov; 7(1):15963. PubMed ID: 29162825
[TBL] [Abstract] [Full Text] [Related]
15. An Integrative Scoring System for Survival Prediction Following Umbilical Cord Blood Transplantation in Acute Leukemia.
Shouval R; Ruggeri A; Labopin M; Mohty M; Sanz G; Michel G; Kuball J; Chevallier P; Al-Seraihy A; Milpied NJ; de Heredia CD; Arcese W; Blaise D; Rocha V; Fein J; Unger R; Baron F; Bader P; Gluckman E; Nagler A
Clin Cancer Res; 2017 Nov; 23(21):6478-6486. PubMed ID: 28754820
[No Abstract] [Full Text] [Related]
16. MiR-193b, downregulated in Ewing Sarcoma, targets the erbb4 oncogene to inhibit anchorage-independent growth.
Moore C; Parrish JK; Jedlicka P
PLoS One; 2017; 12(5):e0178028. PubMed ID: 28542597
[TBL] [Abstract] [Full Text] [Related]
17. High-dose radiotherapy is associated with better local control of bone metastasis from hepatocellular carcinoma.
Jung IH; Yoon SM; Kwak J; Park JH; Song SY; Lee SW; Ahn SD; Choi EK; Kim JH
Oncotarget; 2017 Feb; 8(9):15182-15192. PubMed ID: 28146433
[TBL] [Abstract] [Full Text] [Related]
18. Mutational Profile of Metastatic Breast cancers: A Retrospective Analysis.
Lefebvre C; Bachelot T; Filleron T; Pedrero M; Campone M; Soria JC; Massard C; Lévy C; Arnedos M; Lacroix-Triki M; Garrabey J; Boursin Y; Deloger M; Fu Y; Commo F; Scott V; Lacroix L; Dieci MV; Kamal M; Diéras V; Gonçalves A; Ferrerro JM; Romieu G; Vanlemmens L; Mouret Reynier MA; Théry JC; Le Du F; Guiu S; Dalenc F; Clapisson G; Bonnefoi H; Jimenez M; Le Tourneau C; André F
PLoS Med; 2016 Dec; 13(12):e1002201. PubMed ID: 28027327
[TBL] [Abstract] [Full Text] [Related]
19. EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.
Scheipl S; Barnard M; Cottone L; Jorgensen M; Drewry DH; Zuercher WJ; Turlais F; Ye H; Leite AP; Smith JA; Leithner A; Möller P; Brüderlein S; Guppy N; Amary F; Tirabosco R; Strauss SJ; Pillay N; Flanagan AM
J Pathol; 2016 Jul; 239(3):320-34. PubMed ID: 27102572
[TBL] [Abstract] [Full Text] [Related]
20. Developmental pathways hijacked by osteosarcoma.
Mortus JR; Zhang Y; Hughes DP
Adv Exp Med Biol; 2014; 804():93-118. PubMed ID: 24924170
[TBL] [Abstract] [Full Text] [Related]
[Next]
